FRench Acute Cerebral Multimodal Imaging to Select Patient for MEchanical Thrombectomy (FRAME)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03045146|
Recruitment Status : Completed
First Posted : February 7, 2017
Last Update Posted : November 26, 2019
|Condition or disease||Intervention/treatment|
|Acute Ischemic Stroke||Other: Multimodal brain imaging|
|Study Type :||Observational|
|Actual Enrollment :||220 participants|
|Official Title:||FRench Acute Cerebral Multimodal Imaging to Select Patient for MEchanical Thrombectomy|
|Actual Study Start Date :||January 31, 2017|
|Actual Primary Completion Date :||February 8, 2019|
|Actual Study Completion Date :||April 30, 2019|
Multimodal brain imaging
Consecutive patients experiencing an acute ischemic stroke treated by thrombectomy according to the current recommendations. Clinical outcome will be compared according to the baseline imaging profile processed after patient treatment.
Other: Multimodal brain imaging
Comparison of the Rate of Good Neurological Functional Outcome defined by Modified Rankin Scale 0-2, 3 Months after an acute ischemic stroke treated by thrombectomy according to the presence or not of a Target Mismatch on Baseline imaging (MRI or CTP).
- Modified Rankin Scale [ Time Frame: 3 month ]Good functional outcome will be defined by a Modified Rankin Scale of 0-2, 3 months after stroke onset
- National Institute of Health Scale [ Time Frame: 24 hours, 3 days, 3 months ]
- Symptomatic Hemorrhagic Transformation [ Time Frame: 72 hours ]
Symptomatic hemorrhagic transformation is defined by an intra cerebral hemorrhage associated with a 4 or more point increase on the NIH Stroke Scale by comparison with NIH Stroke Scale immediately predeterioration.
Date and time of onset will be recorded
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03045146
|U H Bordeaux|
|Bordeaux, France, 33000|
|University hospital Toulouse|
|Toulouse, France, 31000|
|Principal Investigator:||Jean-Marc OLIVOT, MD; PHD||UH Toulouse|